title: RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators
authors.affiliation: A. M. Senderowicz, Molecular Therapeutics Unit, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD.
authors.initials: AM
authors.lastname: Senderowicz
authors.initials: EA
authors.lastname: Sausville